Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

Class [042]
Computer & Software Services & Scientific Services

Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor

Class [005]
Pharmaceutical Products

Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor

Mark Details

Serial Number

No 88751607

Mark Type

No Service Mark

Attorney Docket Number

No 230042.205

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
05^th Sep 2023	ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
04^th Sep 2023	ABANDONMENT - NO USE STATEMENT FILED
08^th Feb 2023	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07^th Feb 2023	SOU EXTENSION 5 GRANTED
26^th Jan 2023	CASE ASSIGNED TO INTENT TO USE PARALEGAL
11^th Jan 2023	SOU TEAS EXTENSION RECEIVED
11^th Jan 2023	SOU EXTENSION 5 FILED
28^th Jun 2022	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24^th Jun 2022	SOU TEAS EXTENSION RECEIVED
24^th Jun 2022	SOU EXTENSION 4 FILED

LIVIMMUNE

Classification Information

Class [044]Medical, Beauty & Agricultural Services

Class [042]Computer & Software Services & Scientific Services

Class [005]Pharmaceutical Products